These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 4064559

  • 1. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycollic aciduria).
    Watts RW, Veall N, Purkiss P, Mansell MA, Haywood EF.
    Clin Sci (Lond); 1985 Jul; 69(1):87-90. PubMed ID: 4064559
    [Abstract] [Full Text] [Related]

  • 2. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW, Veall N, Purkiss P.
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [Abstract] [Full Text] [Related]

  • 3. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER, Cohanim M.
    N Engl J Med; 1985 Apr 11; 312(15):953-7. PubMed ID: 3974685
    [Abstract] [Full Text] [Related]

  • 4. Sequential studies of oxalate dynamics in primary hyperoxaluria.
    Watts RW, Veall N, Purkiss P.
    Clin Sci (Lond); 1983 Dec 11; 65(6):627-33. PubMed ID: 6627848
    [Abstract] [Full Text] [Related]

  • 5. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P, Schmidt P, Zazgornik J, Kopsa H, Minar E.
    Proc Eur Dial Transplant Assoc; 1983 Dec 11; 20():417-21. PubMed ID: 6657665
    [Abstract] [Full Text] [Related]

  • 6. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR.
    Nephrol Dial Transplant; 1988 Dec 11; 3(1):28-32. PubMed ID: 3132636
    [Abstract] [Full Text] [Related]

  • 7. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P, Portmann L, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1986 Dec 13; 116(50):1783-6. PubMed ID: 3798070
    [Abstract] [Full Text] [Related]

  • 8. Primary oxalosis: clinical and biochemical response to high-dose pyridoxine therapy.
    Will EJ, Bijvoet OL.
    Metabolism; 1979 May 13; 28(5):542-8. PubMed ID: 449695
    [Abstract] [Full Text] [Related]

  • 9. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
    Garrelfs SF, van Harskamp D, Peters-Sengers H, van den Akker CHP, Wanders RJA, Wijburg FA, van Goudoever JB, Groothoff JW, Schierbeek H, Oosterveld MJS.
    J Am Soc Nephrol; 2021 Dec 01; 32(12):3175-3186. PubMed ID: 34686543
    [Abstract] [Full Text] [Related]

  • 10. Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria.
    Kasidas GP, Nemat S, Rose GA.
    Clin Chim Acta; 1990 Oct 31; 191(1-2):67-77. PubMed ID: 2073734
    [Abstract] [Full Text] [Related]

  • 11. Studies on some possible biochemical treatments of primary hyperoxaluria.
    Watts RW, Chalmers RA, Gibbs DA, Lawson AM, Purkiss P, Spellacy E.
    Q J Med; 1979 Apr 31; 48(190):259-72. PubMed ID: 116301
    [Abstract] [Full Text] [Related]

  • 12. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
    Perinpam M, Enders FT, Mara KC, Vaughan LE, Mehta RA, Voskoboev N, Milliner DS, Lieske JC.
    Clin Biochem; 2017 Dec 31; 50(18):1014-1019. PubMed ID: 28764885
    [Abstract] [Full Text] [Related]

  • 13. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC, Lieske JC, Seide BM, Olson JB, Mehta R, Milliner DS.
    Am J Kidney Dis; 2021 May 31; 77(5):816-819. PubMed ID: 32891627
    [Abstract] [Full Text] [Related]

  • 14. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes.
    Marangella M, Petrarulo M, Vitale C, Cosseddu D, Linari F.
    J Urol; 1992 Sep 31; 148(3 Pt 2):986-9. PubMed ID: 1507356
    [Abstract] [Full Text] [Related]

  • 15. Successful renal transplantation in primary hyperoxaluria.
    O'Regan P, Constable AR, Joekes AM, Kasidas GP, Rose GA.
    Postgrad Med J; 1980 Apr 31; 56(654):288-93. PubMed ID: 7001421
    [Abstract] [Full Text] [Related]

  • 16. Determination of oxalic acid clearance and plasma concentration by radioisotope infusion. Results in a family with hyperoxaluria.
    Prenen JA, Boer P, Dorhout Mees EJ, Endeman HJ, Yoe OH.
    Acta Med Scand; 1981 Apr 31; 209(1-2):87-91. PubMed ID: 7211493
    [Abstract] [Full Text] [Related]

  • 17. Diversity in residual alanine glyoxylate aminotransferase activity in hyperoxaluria type I: correlation with pyridoxine responsiveness.
    Wanders RJ, van Roermund CW, Jurriaans S, Schutgens RB, Tager JM, van den Bosch H, Wolff ED, Przyrembel H, Berger R, Schaaphok FG.
    J Inherit Metab Dis; 1988 Apr 31; 11 Suppl 2():208-11. PubMed ID: 3141704
    [No Abstract] [Full Text] [Related]

  • 18. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P, Nemat S, Rose GA.
    Urol Res; 1990 Apr 31; 18(6):393-6. PubMed ID: 2100414
    [Abstract] [Full Text] [Related]

  • 19. [Hyperoxaluria and renal calculi].
    Buño Soto A, Torres Jiménez R, García Puig J, Mateos Antón F.
    Arch Esp Urol; 1996 Sep 31; 49(7):707-26. PubMed ID: 9020008
    [Abstract] [Full Text] [Related]

  • 20. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
    Mitwalli A, Ayiomamitis A, Grass L, Oreopoulos DG.
    Int Urol Nephrol; 1988 Sep 31; 20(4):353-9. PubMed ID: 3170105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.